← Leaderboards
Boris P. Kovatchev
University Of Virginia Charlottesville
$21,683,171
Attributed
$39,546,270
Total exposure
17
Grants
16
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $13.4M · FY2005–25$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$39,546,270 · 17
By mechanism
R01$17,910,254 · 3
UC4$12,653,694 · 1
DP3$8,084,753 · 2
M01$897,569 · 11
Top collaborators
- Sue A Brown10 shared
- Marc D Breton4 shared
- Francis J Doyle3 shared
- Ananda Basu2 shared
- Stacey Anderson1 shared
- Claudio Cobelli1 shared
- Linda A Gonder-Frederick1 shared
- Yogish C. Kudva1 shared
Others in their field
Top investigators on “Hypoglycemia”
- John M Lachin · George Washington University$122,970,601
- David M Nathan · Massachusetts Institute Of Technology$121,599,449
- Rose A Gubitosi-Klug · Case Western Reserve University$25,202,404
- Roy W Beck · Jaeb Center For Health Research, Inc.$18,504,165
- Boyd E Metzger · Northwestern University$16,155,807
- Charles Alfred Stanley · Children'S Hospital Of Philadelphia$15,091,211
Research focus
HypoglycemiaInsulin-Dependent Diabetes MellitusBaseGlucoseHyperglycemiaInsulinMonitorExerciseRecording Of Previous EventsDiabetes MellitusInsulin Infusion SystemsBehavioralGlycemic ControlArtificial PancreasDesignTechnologyBehavior TherapyAlgorithmsFeedbackBiobehaviorPersonsPhysiologicalResponseBlood Glucose
Grant awards (48)
ADAPTIVE MOTIF-BASED CONTROL (AMBC): A FUNDAMENTALLY NEW APPROACH TO AUTOMATED TREATMENT OPTIMIZATION FOR TYPE 1 DIABETES$681,638
R01 · FY2025 · DK · contact PI
Biobehavioral Human-Machine Co-adaptation of the Artificial Pancreas$672,513
R01 · FY2024 · DK · contact PI
ADAPTIVE MOTIF-BASED CONTROL (AMBC): A FUNDAMENTALLY NEW APPROACH TO AUTOMATED TREATMENT OPTIMIZATION FOR TYPE 1 DIABETES$654,373
R01 · FY2024 · DK · contact PI
Biobehavioral Human-Machine Co-adaptation of the Artificial Pancreas$700,249
R01 · FY2023 · DK · contact PI
ADAPTIVE MOTIF-BASED CONTROL (AMBC): A FUNDAMENTALLY NEW APPROACH TO AUTOMATED TREATMENT OPTIMIZATION FOR TYPE 1 DIABETES$685,566
R01 · FY2023 · DK · contact PI
Biobehavioral Human-Machine Co-adaptation of the Artificial Pancreas$700,539
R01 · FY2022 · DK · contact PI
ADAPTIVE MOTIF-BASED CONTROL (AMBC): A FUNDAMENTALLY NEW APPROACH TO AUTOMATED TREATMENT OPTIMIZATION FOR TYPE 1 DIABETES$686,375
R01 · FY2022 · DK · contact PI
Biobehavioral Human-Machine Co-adaptation of the Artificial Pancreas$700,025
R01 · FY2021 · DK · contact PI
Biobehavioral Human-Machine Co-adaptation of the Artificial Pancreas$700,954
R01 · FY2020 · DK · contact PI
Closed-Loop Control Modalities in Type 1 Diabetes: Efficacy and System Acceptance$702,686
R01 · FY2018 · DK · contact PI
Closed-Loop Control Modalities in Type 1 Diabetes: Efficacy and System Acceptance$701,375
R01 · FY2017 · DK · contact PI
Clinical Acceptance of the Artificial Pancreas: the International Diabetes Closed Loop (iDCL) Trial$12,653,694
UC4 · FY2016 · DK · contact PI
Closed-Loop Control Modalities in Type 1 Diabetes: Efficacy and System Acceptance$700,390
R01 · FY2016 · DK · contact PI
Closed-Loop Control Modalities in Type 1 Diabetes: Efficacy and System Acceptance$698,995
R01 · FY2015 · DK · contact PI
Biobehavioral Triggers, Mechanisms, and Control of Glucose Variability in T1DM$380,709
R01 · FY2015 · DK
Biobehavioral Triggers, Mechanisms, and Control of Glucose Variability in T1DM$380,709
R01 · FY2014 · DK
Ambulatory Artificial Pancreas: merging physiology, behavior, and control design$101,175
DP3 · FY2014 · DK
Network Control of Diabetes: Aligning Artificial Pancreas Design with Physiology$3,441,000
DP3 · FY2013 · DK · contact PI
MODULAR BIO-BEHAVIORAL CLOSED-LOOP CONTROL OF TYPE 1 DIABETES$636,768
R01 · FY2013 · DK · contact PI
Biobehavioral Triggers, Mechanisms, and Control of Glucose Variability in T1DM$396,264
R01 · FY2013 · DK
MODULAR BIO-BEHAVIORAL CLOSED-LOOP CONTROL OF TYPE 1 DIABETES$670,816
R01 · FY2012 · DK · contact PI
Biobehavioral Triggers, Mechanisms, and Control of Glucose Variability in T1DM$407,531
R01 · FY2012 · DK
Ambulatory artificial pancreas: merging physiology, behavior, and controldesign$4,542,578
DP3 · FY2011 · DK
MODULAR BIO-BEHAVIORAL CLOSED-LOOP CONTROL OF TYPE 1 DIABETES$741,698
R01 · FY2011 · DK · contact PI
MODULAR BIO-BEHAVIORAL CLOSED-LOOP CONTROL OF TYPE 1 DIABETES$748,089
R01 · FY2010 · DK · contact PI
IMPROVING METABOLIC CONTROL AND REDUCING HYPOGLYCEMIC RISK IN TYPE 1 DM$44,102
M01 · FY2010 · RR · contact PI
COUNTER-REGULATORY IMPAIRMENT AND MICROVASCULAR INSULIN TRANSFER IN TYPE 1 DM$20,046
M01 · FY2010 · RR · contact PI
Bio-Behavioral Feedback and Control of Type 1 Diabetes$4,000
R01 · FY2010 · DK · contact PI
MODULAR BIO-BEHAVIORAL CLOSED-LOOP CONTROL OF TYPE 1 DIABETES$730,673
R01 · FY2009 · DK · contact PI
Bio-Behavioral Feedback and Control of Type 1 Diabetes$482,952
R01 · FY2009 · DK · contact PI
IMPROVING METABOLIC CONTROL AND REDUCING HYPOGLYCEMIC RISK IN TYPE 1 DM$145,262
M01 · FY2009 · RR · contact PI
STUDY OF CLOSED-LOOP GLUCOSE CONTROL IN PEOPLE WITH TYPE 1 DIABETES$77,016
M01 · FY2009 · RR · contact PI
COUNTER-REGULATORY IMPAIRMENT AND MICROVASCULAR INSULIN TRANSFER IN TYPE 1 DM$47,769
M01 · FY2009 · RR · contact PI
Bio-Behavioral Feedback and Control of Type 1 Diabetes$483,846
R01 · FY2008 · DK · contact PI
IMPROVING METABOLIC CONTROL AND REDUCING HYPOGLYCEMIC RISK IN TYPE 1 DM$185,278
M01 · FY2008 · RR · contact PI
COUNTER-REGULATORY IMPAIRMENT AND MICROVASCULAR INSULIN TRANSFER IN TYPE 1 DM$81,867
M01 · FY2008 · RR · contact PI
Bio-Behavioral Feedback and Control of Type 1 Diabetes$482,958
R01 · FY2007 · DK · contact PI
IMPROVING METABOLIC CONTROL AND REDUCING HYPOGLYCEMIC RISK IN TYPE 1 DM$174,614
M01 · FY2007 · RR · contact PI
COUNTER-REGULATORY IMPAIRMENT AND MICROVASCULAR INSULIN TRANSFER IN TYPE 1 DM$97,106
M01 · FY2007 · RR · contact PI
Bio-Behavioral Feedback and Control of Type 1 Diabetes$485,035
R01 · FY2006 · DK · contact PI
IMPROVING METABOLIC CONTROL AND REDUCING HYPOGLYCEMIC RISK IN TYPE 1 DM$18,381
M01 · FY2006 · RR · contact PI
COUNTER-REGULATORY IMPAIRMENT AND MICROVASCULAR INSULIN TRANSFER IN TYPE 1 DM$6,128
M01 · FY2006 · RR · contact PI
Bio-Behavioral Feedback and Control of Type 1 Diabetes$490,121
R01 · FY2005 · DK
Bio-Behavioral Monitoring and Control of IDDM$331,272
R01 · FY2004 · DK
Bio-Behavioral Monitoring and Control of IDDM$331,272
R01 · FY2003 · DK
Bio-Behavioral Monitoring and Control of IDDM$333,000
R01 · FY2002 · DK
Bio-Behavioral Monitoring and Control of IDDM$333,000
R01 · FY2001 · DK
BIOBEHAVIORAL IRREGULARITY AND CONTROL OF IDDM$73,863
R01 · FY2000 · DK